Modulation of gut microbiota in the management of metabolic disorders: The prospects and challenges

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 4158-4188

  Erejuwa, Omotayo O ^a   Sulaiman, Siti A ^a   Ab Wahab, Mohd S ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Antimicrobial agents; Bariatric surgery; Diabetes mellitus; Fiber; Gut microbiome; Gut microbiota; Metabolic diseases; Microbes; Obesity; Prebiotics; Probiotics

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; ADIPONECTIN RECEPTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CATALASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPOPROTEIN LIPASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

CARDIOVASCULAR DISEASE; COLON CANCER; DIET SUPPLEMENTATION; GENE EXPRESSION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; METABOLIC DISORDER; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; WEIGHT REDUCTION; ANIMAL; BARIATRIC SURGERY; DRUG EFFECTS; GASTROINTESTINAL TRACT; METABOLIC DISEASES; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; ANTI-INFECTIVE AGENTS; BARIATRIC SURGERY; GASTROINTESTINAL TRACT; HUMANS; METABOLIC DISEASES; MICROBIOTA; PREBIOTICS; PROBIOTICS;

EID: 84896449146     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15034158     Document Type: Review

References (128)

1. Dhaliwal, S. S.; Welborn, T. A. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: A public health perspective. Prev. Med. 2009, 49, 153-157.
2. Matheus, A. S.; Tannus, L. R.; Cobas, R. A.; Palma, C. C.; Negrato, C. A.; Gomes Mde, B. Impact of diabetes on cardiovascular disease: An update. Int. J. Hypertens. 2013, 2013, 653789.
3. Rao, H. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Indian Heart J. 2012, 64, 113.
4. McCarthy, M. I. Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 2010, 363, 2339-2350.
5. Grenham, S.; Clarke, G.; Cryan, J. F.; Dinan, T. G. Brain-gut-microbe communication in health and disease. Front. Physiol. 2011, 2, 94.
6. Leser, T. D.; Molbak, L. Better living through microbial action: The benefits of the mammalian gastrointestinal microbiota on the host. Environ. Microbiol. 2009, 11, 2194-2206.
7. Purchiaroni, F.; Tortora, A.; Gabrielli, M.; Bertucci, F.; Gigante, G.; Ianiro, G.; Ojetti, V.; Scarpellini, E.; Gasbarrini, A. The role of intestinal microbiota and the immune system. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 323-333.
8. Jumpertz, R.; Le, D. S.; Turnbaugh, P. J.; Trinidad, C.; Bogardus, C.; Gordon, J. I.; Krakoff, J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 2011, 94, 58-65.
9. Blumberg, R.; Powrie, F. Microbiota, disease, and back to health: A metastable journey. Sci. Transl. Med. 2012, 4, 137rv7.
10. Karlsson, F.; Tremaroli, V.; Nielsen, J.; Backhed, F. Assessing the human gut microbiota in metabolic diseases. Diabetes 2013, 62, 3341-3349.
11. Musso, G.; Gambino, R.; Cassader, M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: Mechanisms and implications for metabolic disorders. Curr. Opin. Lipidol. 2010, 21, 76-83.
12. Coates, M. E. Gnotobiotic animals in research: Their uses and limitations. Lab. Anim. 1975, 9, 275-282.
13. Backhed, F.; Ding, H.; Wang, T.; Hooper, L. V.; Koh, G. Y.; Nagy, A.; Semenkovich, C. F.; Gordon, J. I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718-15723.
14. Backhed, F.; Manchester, J. K.; Semenkovich, C. F.; Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 2007, 104, 979-984.
15. Turnbaugh, P. J.; Ley, R. E.; Mahowald, M. A.; Magrini, V.; Mardis, E. R.; Gordon, J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027-1031.
16. Ley, R. E.; Backhed, F.; Turnbaugh, P.; Lozupone, C. A.; Knight, R. D.; Gordon, J. I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070-11075.
17. Turnbaugh, P. J.; Backhed, F.; Fulton, L.; Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3, 213-223.
18. Turnbaugh, P. J.; Hamady, M.; Yatsunenko, T.; Cantarel, B. L.; Duncan, A.; Ley, R. E.; Sogin, M. L.; Jones, W. J.; Roe, B. A.; Affourtit, J. P.; et al. A core gut microbiome in obese and lean twins. Nature 2009, 457, 480-484.
19. Kim, K. A.; Gu, W.; Lee, I. A.; Joh, E. H.; Kim, D. H. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7, e47713.
20. Verdam, F. J.; Fuentes, S.; de Jonge, C.; Zoetendal, E. G.; Erbil, R.; Greve, J. W.; Buurman, W. A.; de Vos, W. M.; Rensen, S. S. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 2013, 21, E607-E615.
21. Ley, R. E.; Turnbaugh, P. J.; Klein, S.; Gordon, J. I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
22. Million, M.; Angelakis, E.; Maraninchi, M.; Henry, M.; Giorgi, R.; Valero, R.; Vialettes, B.; Raoult, D. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int. J. Obes. (Lond.) 2013, 37, 1460-1466.
23. Million, M.; Maraninchi, M.; Henry, M.; Armougom, F.; Richet, H.; Carrieri, P.; Valero, R.; Raccah, D.; Vialettes, B.; Raoult, D. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. (Lond.) 2012, 36, 817-825.
24. Serino, M.; Fernandez-Real, J. M.; Fuentes, E. G.; Queipo-Ortuno, M.; Moreno-Navarrete, J. M.; Sanchez, A.; Burcelin, R.; Tinahones, F. The gut microbiota profile is associated with insulin action in humans. Acta Diabetol. 2012, 50, 753-761.
25. Zhang, H.; DiBaise, J. K.; Zuccolo, A.; Kudrna, D.; Braidotti, M.; Yu, Y.; Parameswaran, P.; Crowell, M. D.; Wing, R.; Rittmann, B. E.; et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. USA 2009, 106, 2365-2370.
26. Greiner, T.; Backhed, F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol. Metab. 2011, 22, 117-123.
27. Brown, A. J.; Goldsworthy, S. M.; Barnes, A. A.; Eilert, M. M.; Tcheang, L.; Daniels, D.; Muir, A. I.; Wigglesworth, M. J.; Kinghorn, I.; Fraser, N. J.; et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278, 11312-11319.
28. Manco, M.; Putignani, L.; Bottazzo, G. F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr. Rev. 2010, 31, 817-844.
29. Cani, P. D.; Amar, J.; Iglesias, M. A.; Poggi, M.; Knauf, C.; Bastelica, D.; Neyrinck, A. M.; Fava, F.; Tuohy, K. M.; Chabo, C.; et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
30. Rodes, L.; Khan, A.; Paul, A.; Coussa-Charley, M.; Marinescu, D.; Tomaro-Duchesneau, C.; Shao, W.; Kahouli, I.; Prakash, S. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: An in vitro study using a human colonic microbiota model. J. Microbiol. Biotechnol. 2013, 23, 518-526.
31. Murri, M.; Leiva, I.; Gomez-Zumaquero, J. M.; Tinahones, F. J.; Cardona, F.; Soriguer, F.; Queipo-Ortuno, M. I. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med. 2013, 11, 46.
32. Larsen, N.; Vogensen, F. K.; van den Berg, F. W.; Nielsen, D. S.; Andreasen, A. S.; Pedersen, B. K.; Al-Soud, W. A.; Sorensen, S. J.; Hansen, L. H.; Jakobsen, M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5, e9085.
33. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
34. Tagliabue, A.; Elli, M. The role of gut microbiota in human obesity: Recent findings and future perspectives. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 160-168.
35. Stachowicz, N.; Kiersztan, A. The role of gut microbiota in the pathogenesis of obesity and diabetes. Postep. Hig. Med. Dosw. 2013, 67, 288-303.
36. Caricilli, A. M.; Saad, M. J. The role of gut microbiota on insulin resistance. Nutrients 2013, 5, 829-851.
37. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food; Report of a Joint Food and Agriculture Organization of the United Nations/World Health Organization Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food: London, Ontario, Canada, 30 April and 1 May 2002. Available online: http://www. who. int/foodsafety/fs_management/en/probiotic_guidelines. pdf?ua=1.
38. Duan, F.; Curtis, K. L.; March, J. C. Secretion of insulinotropic proteins by commensal bacteria: Rewiring the gut to treat diabetes. Appl. Environ. Microbiol. 2008, 74, 7437-7438.
39. Hsieh, F. C.; Lee, C. L.; Chai, C. Y.; Chen, W. T.; Lu, Y. C.; Wu, C. S. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr. Metab. 2013, 10, 35.
40. Sakai, T.; Taki, T.; Nakamoto, A.; Shuto, E.; Tsutsumi, R.; Toshimitsu, T.; Makino, S.; Ikegami, S. Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat diet. J. Nutr. Sci. Vitaminol. 2013, 59, 144-147.
41. Bejar, W.; Hamden, K.; Salah, R. B.; Chouayekh, H. Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe 2013, 24, 4-11.
42. Park, J. E.; Oh, S. H.; Cha, Y. S. Lactobacillus plantarum LG42 isolated from gajami sik-hae decreases body and fat pad weights in diet-induced obese mice. J. Appl. Microbiol. 2014, 116, 145-156.
43. Yadav, H.; Jain, S.; Sinha, P. R. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J. Dairy Res. 2008, 75, 189-195.
44. Kang, J. H.; Yun, S. I.; Park, M. H.; Park, J. H.; Jeong, S. Y.; Park, H. O. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 2013, 8, e54617.
45. Kim, S. W.; Park, K. Y.; Kim, B.; Kim, E.; Hyun, C. K. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem. Biophys. Res. Commun. 2013, 431, 258-263.
46. Zhang, Y.; Wang, L.; Zhang, J.; Li, Y.; He, Q.; Li, H.; Guo, X.; Guo, J.; Zhang, H. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur. J. Nutr. 2014, 53, 221.
47. Andreasen, A. S.; Larsen, N.; Pedersen-Skovsgaard, T.; Berg, R. M.; Moller, K.; Svendsen, K. D.; Jakobsen, M.; Pedersen, B. K. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 2010, 104, 1831-1838.
48. Asemi, Z.; Samimi, M.; Tabassi, Z.; Naghibi Rad, M.; Rahimi Foroushani, A.; Khorammian, H.; Esmaillzadeh, A. Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: A randomized controlled trial. Eur. J. Clin. Nutr. 2013, 67, 71-74.
49. Ejtahed, H. S.; Mohtadi-Nia, J.; Homayouni-Rad, A.; Niafar, M.; Asghari-Jafarabadi, M.; Mofid, V.; Akbarian-Moghari, A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 2011, 94, 3288-3294.
50. Ejtahed, H. S.; Mohtadi-Nia, J.; Homayouni-Rad, A.; Niafar, M.; Asghari-Jafarabadi, M.; Mofid, V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012, 28, 539-543.
51. Asemi, Z.; Zare, Z.; Shakeri, H.; Sabihi, S. S.; Esmaillzadeh, A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nutr. Metab. 2013, 63, 1-9.
52. Kadooka, Y.; Sato, M.; Imaizumi, K.; Ogawa, A.; Ikuyama, K.; Akai, Y.; Okano, M.; Kagoshima, M.; Tsuchida, T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 2010, 64, 636-643.
53. Jung, S. P.; Lee, K. M.; Kang, J. H.; Yun, S. I.; Park, H. O.; Moon, Y.; Kim, J. Y. Effect of lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial. Korean J. Fam. Med. 2013, 34, 80-89.
54. Panwar, H.; Calderwood, D.; Grant, I. R.; Grover, S.; Green, B. D. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha-and beta-glucosidases suggesting anti-diabetic potential. Eur. J. Nutr. 2014, doi: 10. 1007/s00394-013-0649-9.
55. Ataie-Jafari, A.; Larijani, B.; Alavi Majd, H.; Tahbaz, F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 2009, 54, 22-27.
56. Mazloom, Z.; Yousefinejad, A.; Dabbaghmanesh, M. H. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran. J. Med. Sci. 2013, 38, 38-43.
57. Rad, H. The effects of probiotic yoghurt on C-Reactive Protein in type 2 diabetic patients. Yafteh 2013, 15, 95-104.
58. Stsepetova, J.; Sepp, E.; Kolk, H.; Loivukene, K.; Songisepp, E.; Mikelsaar, M. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br. J. Nutr. 2011, 105, 1235-1244.
59. Gibson, G. R. Prebiotics as gut microflora management tools. J. Clin. Gastroenterol. 2008, 42, S75-S79.
60. Everard, A.; Lazarevic, V.; Derrien, M.; Girard, M.; Muccioli, G. G.; Neyrinck, A. M.; Possemiers, S.; Van Holle, A.; Francois, P.; de Vos, W. M.; et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60, 2775-2786.
61. Parnell, J. A.; Reimer, R. A. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR: LA-cp rats. Br. J. Nutr. 2012, 107, 601-613.
62. Dewulf, E. M.; Cani, P. D.; Neyrinck, A. M.; Possemiers, S.; Van Holle, A.; Muccioli, G. G.; Deldicque, L.; Bindels, L. B.; Pachikian, B. D.; Sohet, F. M.; et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J. Nutr. Biochem. 2011, 22, 712-722.
63. Neyrinck, A. M.; Possemiers, S.; Druart, C.; Van de Wiele, T.; De Backer, F.; Cani, P. D.; Larondelle, Y.; Delzenne, N. M. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 2011, 6, e20944.
64. Kajiwara, S.; Gandhi, H.; Ustunol, Z. Effect of honey on the growth of and acid production by human intestinal Bifidobacterium spp.: An in vitro comparison with commercial oligosaccharides and inulin. J. Food Prot. 2002, 65, 214-218.
65. Sanz, M. L.; Polemis, N.; Morales, V.; Corzo, N.; Drakoularakou, A.; Gibson, G. R.; Rastall, R. A. In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J. Agric. Food Chem. 2005, 53, 2914-2921.
66. Erejuwa, O. O.; Sulaiman, S. A.; Wahab, M. S. Oligosaccharides might contribute to the antidiabetic effect of honey: A review of the literature. Molecules 2011, 17, 248-266.
67. Erejuwa, O. O.; Sulaiman, S. A.; Wahab, M. S.; Sirajudeen, K. N.; Salleh, M. S.; Gurtu, S. Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int. J. Biol. Sci. 2011, 7, 244-252.
68. Kuo, S. M.; Merhige, P. M.; Hagey, L. R. The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10-/-mice. PLoS One 2013, 8, e60270.
69. Walsh, A. M.; Sweeney, T.; O'Shea, C. J.; Doyle, D. N.; O'Doherty, J. V. Effect of dietary laminarin and fucoidan on selected microbiota, intestinal morphology and immune status of the newly weaned pig. Br. J. Nutr. 2013, 1-9.
70. Cani, P. D.; Lecourt, E.; Dewulf, E. M.; Sohet, F. M.; Pachikian, B. D.; Naslain, D.; De Backer, F.; Neyrinck, A. M.; Delzenne, N. M. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009, 90, 1236-1243.
71. Parnell, J. A.; Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89, 1751-1759.
72. Sasaki, M.; Ogasawara, N.; Funaki, Y.; Mizuno, M.; Iida, A.; Goto, C.; Koikeda, S.; Kasugai, K.; Joh, T. Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: A randomized double-blind, placebo-controlled study. BMC Gastroenterol. 2013, 13, 81.
73. McNeil, N. I. The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr. 1984, 39, 338-342.
74. Hu, G. X.; Chen, G. R.; Xu, H.; Ge, R. S.; Lin, J. Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med. Hypotheses 2010, 74, 123-126.
75. Gao, Z.; Yin, J.; Zhang, J.; Ward, R. E.; Martin, R. J.; Lefevre, M.; Cefalu, W. T.; Ye, J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58, 1509-1517.
76. Lappi, J.; Salojarvi, J.; Kolehmainen, M.; Mykkanen, H.; Poutanen, K.; de Vos, W. M.; Salonen, A. Intake of whole-grain and fiber-rich rye bread versus refined wheat bread does not differentiate intestinal microbiota composition in Finnish adults with metabolic syndrome. J. Nutr. 2013, 143, 648-655.
77. Weickert, M. O.; Arafat, A. M.; Blaut, M.; Alpert, C.; Becker, N.; Leupelt, V.; Rudovich, N.; Mohlig, M.; Pfeiffer, A. F. Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr. Metab. 2011, 8, 90.
78. Baer, D. J.; Rumpler, W. V.; Miles, C. W.; Fahey, G. C., Jr. Dietary fiber decreases the metabolizable energy content and nutrient digestibility of mixed diets fed to humans. J. Nutr. 1997, 127, 579-586.
79. Isken, F.; Klaus, S.; Osterhoff, M.; Pfeiffer, A. F.; Weickert, M. O. Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J. Nutr. Biochem. 2010, 21, 278-284.
80. Membrez, M.; Blancher, F.; Jaquet, M.; Bibiloni, R.; Cani, P. D.; Burcelin, R. G.; Corthesy, I.; Mace, K.; Chou, C. J. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22, 2416-2426.
81. Carvalho, B. M.; Guadagnini, D.; Tsukumo, D. M.; Schenka, A. A.; Latuf-Filho, P.; Vassallo, J.; Dias, J. C.; Kubota, L. T.; Carvalheira, J. B.; Saad, M. J. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012, 55, 2823-2834.
82. Bergheim, I.; Weber, S.; Vos, M.; Kramer, S.; Volynets, V.; Kaserouni, S.; McClain, C. J.; Bischoff, S. C. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin. J. Hepatol. 2008, 48, 983-992.
83. Cho, I.; Yamanishi, S.; Cox, L.; Methe, B. A.; Zavadil, J.; Li, K.; Gao, Z.; Mahana, D.; Raju, K.; Teitler, I.; et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488, 621-626.
84. Bech-Nielsen, G. V.; Hansen, C. H.; Hufeldt, M. R.; Nielsen, D. S.; Aasted, B.; Vogensen, F. K.; Midtvedt, T.; Hansen, A. K. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Res. Vet. Sci. 2012, 92, 501-508.
85. Murphy, E. F.; Cotter, P. D.; Hogan, A.; O'Sullivan, O.; Joyce, A.; Fouhy, F.; Clarke, S. F.; Marques, T. M.; O'Toole, P. W.; Stanton, C.; et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 2013, 62, 220-226.
86. Hansen, C. H.; Krych, L.; Nielsen, D. S.; Vogensen, F. K.; Hansen, L. H.; Sorensen, S. J.; Buschard, K.; Hansen, A. K. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 2012, 55, 2285-2294.
87. Erejuwa, O. O.; Gurtu, S.; Sulaiman, S. A.; Ab Wahab, M. S.; Sirajudeen, K. N.; Salleh, M. S. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res. 2010, 80, 74-82.
88. Erejuwa, O. O.; Sulaiman, S. A.; Wahab, M. S.; Sirajudeen, K. N.; Salleh, M. S.; Gurtu, S. Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: Effects of antioxidant (honey) treatment. Int. J. Mol. Sci. 2011, 12, 1888-1907.
89. Nemoseck, T. M.; Carmody, E. G.; Furchner-Evanson, A.; Gleason, M.; Li, A.; Potter, H.; Rezende, L. M.; Lane, K. J.; Kern, M. Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr. Res. 2011, 31, 55-60.
90. Jernberg, C.; Lofmark, S.; Edlund, C.; Jansson, J. K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1, 56-66.
91. O'Sullivan, O.; Coakley, M.; Lakshminarayanan, B.; Conde, S.; Claesson, M. J.; Cusack, S.; Fitzgerald, A. P.; O'Toole, P. W.; Stanton, C.; Ross, R. P. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J. Antimicrob. Chemother. 2013, 68, 214-221.
92. Kong, L. C.; Tap, J.; Aron-Wisnewsky, J.; Pelloux, V.; Basdevant, A.; Bouillot, J. L.; Zucker, J. D.; Dore, J.; Clement, K. Gut microbiota after gastric bypass in human obesity: Increased richness and associations of bacterial genera with adipose tissue genes. Am. J. Clin. Nutr. 2013, 98, 16-24.
93. Kashyap, S. R.; Bhatt, D. L.; Wolski, K.; Watanabe, R. M.; Abdul-Ghani, M.; Abood, B.; Pothier, C. E.; Brethauer, S.; Nissen, S.; Gupta, M.; et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013, 36, 2175-2182.
94. Lips, M. A.; de Groot, G. H.; van Klinken, J. B.; Aarts, E.; Berends, F. J.; Janssen, I. M.; van Ramshorst, B.; van Wagensveld, B. A.; Swank, D. J.; van Dielen, F.; et al. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clin. Endocrinol. 2013, doi: 10. 1111/cen. 12254.
95. Graessler, J.; Qin, Y.; Zhong, H.; Zhang, J.; Licinio, J.; Wong, M. L.; Xu, A.; Chavakis, T.; Bornstein, A. B.; Ehrhart-Bornstein, M.; et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: Correlation with inflammatory and metabolic parameters. Pharmacogenomics J. 2013, 13, 514-522.
96. Duncan, S. H.; Belenguer, A.; Holtrop, G.; Johnstone, A. M.; Flint, H. J.; Lobley, G. E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73, 1073-1078.
97. Duncan, S. H.; Lobley, G. E.; Holtrop, G.; Ince, J.; Johnstone, A. M.; Louis, P.; Flint, H. J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond.) 2008, 32, 1720-1724.
98. Kim, M. S.; Hwang, S. S.; Park, E. J.; Bae, J. W. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ. Microbiol. Rep. 2013, 5, 765-775.
99. Santacruz, A.; Marcos, A.; Warnberg, J.; Marti, A.; Martin-Matillas, M.; Campoy, C.; Moreno, L. A.; Veiga, O.; Redondo-Figuero, C.; Garagorri, J. M.; et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009, 17, 1906-1915.
100. Nadal, I.; Santacruz, A.; Marcos, A.; Warnberg, J.; Garagorri, J. M.; Moreno, L. A.; Martin-Matillas, M.; Campoy, C.; Marti, A.; Moleres, A.; et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int. J. Obes. (Lond.) 2009, 33, 758-767.
101. Hussey, S.; Wall, R.; Gruffman, E.; O'Sullivan, L.; Ryan, C. A.; Murphy, B.; Fitzgerald, G.; Stanton, C.; Ross, R. P. Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. Int. J. Microbiol. 2011, 2011, doi: 10. 1155/2011/130574.
102. Hernandez, E.; Bargiela, R.; Diez, M. S.; Friedrichs, A.; Perez-Cobas, A. E.; Gosalbes, M. J.; Knecht, H.; Martinez-Martinez, M.; Seifert, J.; von Bergen, M.; et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 2013, 4, 306-315.
103. Jernberg, C.; Lofmark, S.; Edlund, C.; Jansson, J. K. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156, 3216-3223.
104. Stefater, M. A.; Kohli, R.; Inge, T. H. Advances in the surgical treatment of morbid obesity. Mol. Aspects Med. 2013, 34, 84-94.
105. Li, J. V.; Ashrafian, H.; Bueter, M.; Kinross, J.; Sands, C.; le Roux, C. W.; Bloom, S. R.; Darzi, A.; Athanasiou, T.; Marchesi, J. R.; et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011, 60, 1214-1223.
106. Liou, A. P.; Paziuk, M.; Luevano, J. M., Jr.; Machineni, S.; Turnbaugh, P. J.; Kaplan, L. M. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci. Transl. Med. 2013, 5, 178ra41.
107. Everard, A.; Belzer, C.; Geurts, L.; Ouwerkerk, J. P.; Druart, C.; Bindels, L. B.; Guiot, Y.; Derrien, M.; Muccioli, G. G.; Delzenne, N. M.; et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 2013, 110, 9066-9071.
108. Sweeney, T. E.; Morton, J. M. The human gut microbiome: A review of the effect of obesity and surgically induced weight loss. JAMA Surg. 2013, 148, 563-569.
109. Vetter, M. L.; Wadden, T. A.; Chittams, J.; Diewald, L. K.; Panigrahi, E.; Volger, S.; Sarwer, D. B.; Moore, R. H. Effect of lifestyle intervention on cardiometabolic risk factors: Results of the POWER-UP trial. Int. J. Obes. (Lond.) 2013, 37, S19-S24.
110. Zhang, C.; Li, S.; Yang, L.; Huang, P.; Li, W.; Wang, S.; Zhao, G.; Zhang, M.; Pang, X.; Yan, Z.; et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat. Commun. 2013, 4, 2163.
111. Phillips, F.; Hackett, A. F.; Stratton, G.; Billington, D. Effect of changing to a self-selected vegetarian diet on anthropometric measurements in UK adults. J. Hum. Nutr. Diet. 2004, 17, 249-255.
112. Simon, C.; Daniel, R. Metagenomic analyses: Past and future trends. Appl. Environ. Microbiol. 2011, 77, 1153-1161.
113. Benson, A. K.; Kelly, S. A.; Legge, R.; Ma, F.; Low, S. J.; Kim, J.; Zhang, M.; Oh, P. L.; Nehrenberg, D.; Hua, K.; et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl. Acad. Sci. USA 2010, 107, 18933-18938.
114. Ferrer, M.; Ruiz, A.; Lanza, F.; Haange, S. B.; Oberbach, A.; Till, H.; Bargiela, R.; Campoy, C.; Segura, M. T.; Richter, M.; et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ. Microbiol. 2013, 15, 211-226.
115. Sousa, T.; Paterson, R.; Moore, V.; Carlsson, A.; Abrahamsson, B.; Basit, A. W. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 2008, 363, 1-25.
116. Zimmer, J.; Lange, B.; Frick, J. S.; Sauer, H.; Zimmermann, K.; Schwiertz, A.; Rusch, K.; Klosterhalfen, S.; Enck, P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 2012, 66, 53-60.
117. Nursten, H. E. The Maillard Reaction. Chemistry, Biochemistry, and Implications; Royal Society of Chemistry: Cambridge, UK, 2005.
118. Zhang, Q.; Ames, J. M.; Smith, R. D.; Baynes, J. W.; Metz, T. O. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: Probing the pathogenesis of chronic disease. J. Proteome Res. 2009, 8, 754-769.
119. Mills, D. J.; Tuohy, K. M.; Booth, J.; Buck, M.; Crabbe, M. J.; Gibson, G. R.; Ames, J. M. Dietary glycated protein modulates the colonic microbiota towards a more detrimental composition in ulcerative colitis patients and non-ulcerative colitis subjects. J. Appl. Microbiol. 2008, 105, 706-714.
120. Koeth, R. A.; Wang, Z.; Levison, B. S.; Buffa, J. A.; Org, E.; Sheehy, B. T.; Britt, E. B.; Fu, X.; Wu, Y.; Li, L.; et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19, 576-585.
121. Tang, W. H.; Wang, Z.; Levison, B. S.; Koeth, R. A.; Britt, E. B.; Fu, X.; Wu, Y.; Hazen, S. L. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 2013, 368, 1575-1584.
122. Cotter, P. D.; Stanton, C.; Ross, R. P.; Hill, C. The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov. Med. 2012, 13, 193-199.
123. Jakobsson, H. E.; Jernberg, C.; Andersson, A. F.; Sjolund-Karlsson, M.; Jansson, J. K.; Engstrand, L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010, 5, e9836.
124. Trasande, L.; Blustein, J.; Liu, M.; Corwin, E.; Cox, L. M.; Blaser, M. J. Infant antibiotic exposures and early-life body mass. Int. J. Obes. (Lond.) 2013, 37, 16-23.
125. Cryan, J. F.; Dinan, T. G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 2012, 13, 701-712.
126. Manco, M. Gut microbiota and developmental programming of the brain: From evidence in behavioral endophenotypes to novel perspective in obesity. Front. Cell. Infect. Microbiol. 2012, 2, 109.
127. Carvalho, F. A.; Aitken, J. D.; Vijay-Kumar, M.; Gewirtz, A. T. Toll-like receptor-gut microbiota interactions: Perturb at your own risk! Annu. Rev. Physiol. 2012, 74, 177-198.
128. De Filippo, C.; Cavalieri, D.; di Paola, M.; Ramazzotti, M.; Poullet, J. B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691-14696.